Steve Daly

Steve Daly has achieved 30 years of commercial clinical success including key milestones in start-up management. In the mid 2000s Steve was at the helm of the flagship product Symlin® at the San Diego biotech, Amylin Pharmaceuticals. Steve went on to become the marketing lead at Affymax, VP Sales and Marketing at Halozyme, and recently, the US General Manager for the French biotech, Adocia. In 2021 Steve Daly joined AseptiScope as the Chief Commercial Officer.